Blue Zone Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Blue Zone Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.82M	Buy	11,048 +431	+4%	+$242K	1.02%	34
2026 Q1	$5.97M	Sell	10,617 -1,050	-9%	-$673K	1.21%	34
2025 Q4	$7.89M	Sell	11,667 -325	-3%	-$221K	1.51%	22
2025 Q3	$7.66M	Buy	11,992 +135	+1%	+$81.9K	1.53%	20
2025 Q2	$6.36M	Buy	11,857 +556	+5%	+$266K	1.59%	25
2025 Q1	$4.75M	Buy	11,301 +1,727	+18%	+$750K	1.32%	37
2024 Q4	$3.96M	Buy	+9,574	New	+$4.2M	1.14%	43

Other funds holding IDXX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

MIM

Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

HCM

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Blue Zone Wealth Advisors's IDXX Position: Q2 2026 in Review

Blue Zone Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 4.1% in Q2 2026, buying an estimated $242K and bringing the position to 11,048 shares worth $5.82M. The position accounts for 1.02% of the portfolio, ranked #34.

Blue Zone Wealth Advisors first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.89M in Q4 2025. 173 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Blue Zone Wealth Advisors held 11,048 shares of Idexx Laboratories worth $5.82M as of Q2 2026.
Blue Zone Wealth Advisors bought 431 Idexx Laboratories shares in Q2 2026, an estimated $242K.
Idexx Laboratories made up 1.02% of Blue Zone Wealth Advisors's portfolio in Q2 2026, its #34 holding.
Blue Zone Wealth Advisors first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
Blue Zone Wealth Advisors's Idexx Laboratories position peaked at $7.89M in Q4 2025.
173 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Blue Zone Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.